Company

MedVee

Telehealth provider offering GLP-1 weight loss drugs, reportedly on track for $1.8B in annual revenue with a two-person founding team

Healthcare & Biotech

People

Matthew Gallagherfounder

News

Interviews (1)

Dr. Jonathan Slotkin breaks down MedVee: fake doctors, oral GLP-1s with zero evidence, and regulatory gaps enabling bad actors

Mentioned (1)

MedVee's $1B claim unravels: FDA warning letters, fake doctors, and razor-thin GLP-1 margins